F8 and hemophilia: Contemporary treatment available for hemophilia involves very tedious and regular (about 2–3 times per week) intravenous infusion of recombinant or FVIII/FIX proteins (both of which are secreted in inactive form at plasma levels of 200 and 5,000 ng/mL, respectively) derived from the plasma.